CSL - Sales Revenues


CSL reported $8.33B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 110.08M 109.89M Dec/2025
Bio Path 0 0 Mar/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
CSL USD 8.33B 4.79B Dec/2025
Curis USD 1.14M 1.41M Dec/2025
Esperion Therapeutics USD 168.45M 81.14M Dec/2025
Minerva Neurosciences USD 0 0 Sep/2024
Sangamo BioSciences USD 356K 125K Jun/2024
TherapeuticsMD USD 234K 79K Jun/2024